Literature DB >> 20065077

Hereditary myeloproliferative disorders.

Radek C Skoda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20065077      PMCID： PMC2805753          DOI： 10.3324/haematol.2009.015941

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  28 in total

1.  Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer.

Authors:  M Onishi; A L Mui; Y Morikawa; L Cho; S Kinoshita; G P Nolan; D M Gorman; A Miyajima; T Kitamura
Journal:  Blood       Date:  1996-08-15       Impact factor: 22.113

Review 2.  Translational pathophysiology: a novel molecular mechanism of human disease.

Authors:  M Cazzola; R C Skoda
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

3.  Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia.

Authors:  Sonny O Ang; Hua Chen; Kiichi Hirota; Victor R Gordeuk; Jaroslav Jelinek; Yongli Guan; Enli Liu; Adelina I Sergueeva; Galina Y Miasnikova; David Mole; Patrick H Maxwell; David W Stockton; Gregg L Semenza; Josef T Prchal
Journal:  Nat Genet       Date:  2002-11-04       Impact factor: 38.330

4.  Autosomal dominant polycythemia.

Authors:  J T Prchal; W M Crist; E Goldwasser; G Perrine; J F Prchal
Journal:  Blood       Date:  1985-11       Impact factor: 22.113

5.  Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia.

Authors:  Kun Liu; Maurizio Martini; Bianca Rocca; Christopher I Amos; Luciana Teofili; Fiorina Giona; Jianmin Ding; Hirokazu Komatsu; Luigi M Larocca; Radek C Skoda
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

Review 6.  Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.

Authors:  Gregg L Semenza
Journal:  Blood       Date:  2009-06-03       Impact factor: 22.113

7.  Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis.

Authors:  Luciana Teofili; Fiorina Giona; Lorenza Torti; Tonia Cenci; Bianca Maria Ricerca; Carlo Rumi; Vittorio Nunes; Robin Foà; Giuseppe Leone; Maurizio Martini; Luigi Maria Larocca
Journal:  Haematologica       Date:  2009-08-27       Impact factor: 9.941

8.  Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis.

Authors:  Alison R Moliterno; Donna M Williams; Laura I Gutierrez-Alamillo; Roberto Salvatori; Roxann G Ingersoll; Jerry L Spivak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-21       Impact factor: 11.205

9.  Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin.

Authors:  Jianmin Ding; Hirokazu Komatsu; Atsushi Wakita; Miyuki Kato-Uranishi; Masato Ito; Atsushi Satoh; Kazuya Tsuboi; Masakazu Nitta; Hiroshi Miyazaki; Shinsuke Iida; Ryuzo Ueda
Journal:  Blood       Date:  2004-02-05       Impact factor: 22.113

10.  Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis.

Authors:  A de la Chapelle; A L Träskelin; E Juvonen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205
View more
  5 in total

1.  Inherited predisposition to myeloproliferative neoplasms.

Authors:  Amy V Jones; Nicholas C P Cross
Journal:  Ther Adv Hematol       Date:  2013-08

Review 2.  [Myeloproliferative neoplasms: histopathological and molecular pathological diagnosis].

Authors:  K Hussein; G Büsche; J Schlue; U Lehmann; H Kreipe
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

3.  HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression.

Authors:  Liping Li; Jung-Hyun Kim; Wenyan Lu; Donna M Williams; Joseph Kim; Leslie Cope; Raajit K Rampal; Richard P Koche; Lingling Xian; Li Z Luo; Marija Vasiljevic; Daniel R Matson; Zhizhuang Joe Zhao; Ophelia Rogers; Matthew C Stubbs; Karen Reddy; Antonio-Rodriguez Romero; Bethan Psaila; Jerry L Spivak; Alison R Moliterno; Linda M S Resar
Journal:  Blood       Date:  2022-05-05       Impact factor: 25.476

4.  Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations.

Authors:  Stephen E Langabeer; Karl Haslam; Jennifer Linders; Melanie J Percy; Eibhlin Conneally; Amjad Hayat; Brian Hennessy; Maeve Leahy; Karen Murphy; Margaret Murray; Fionnuala Ni Ainle; Patrick Thornton; Jeremy Sargent
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

Review 5.  Back to biology: new insights on inheritance in myeloproliferative disorders.

Authors:  Evan M Braunstein; Alison R Moliterno
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.